40 min listen
What Clinicians Want to Know About Toxicity Considerations Associated with BTK Inhibitors
What Clinicians Want to Know About Toxicity Considerations Associated with BTK Inhibitors
ratings:
Length:
63 minutes
Released:
Sep 22, 2023
Format:
Podcast episode
Description
Dr Nicole Lamanna from the Columbia University Herbert Irving Comprehensive Cancer Center in New York, New York, and Dr William G Wierda from The University of Texas MD Anderson Cancer Center in Houston, Texas, discuss the spectrum of toxicities associated with BTK inhibitors and strategies for their mitigation and management for patients with chronic lymphocytic leukemia and mantle cell lymphoma.
Released:
Sep 22, 2023
Format:
Podcast episode
Titles in the series (100)
HOU1 2008 | Interview with Susan M O’Brien, MD: HematologicOncologyUpdate.com – Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Interviews conducted by Neil Love, MD. Produced by Research To Practice. by Hematologic Oncology Update